Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas
This study is currently recruiting participants.
Study NCT00528684   Information provided by Oncolytics Biotech
First Received: September 10, 2007   Last Updated: August 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Glioma
Additional conditions recognized in this trial
Glioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Interventions listed in this trial
REOLYSIN®
Sponsors listed in this trial
Oncolytics Biotech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services